A detailed history of Cetera Investment Advisers transactions in Stryker Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 91,767 shares of SYK stock, worth $35.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
91,767
Previous 89,948 2.02%
Holding current value
$35.3 Million
Previous $30.6 Million 8.31%
% of portfolio
0.07%
Previous 0.07%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$315.94 - $371.96 $574,694 - $676,595
1,819 Added 2.02%
91,767 $33.1 Million
Q2 2024

Aug 22, 2024

BUY
$324.3 - $354.67 $719,946 - $787,367
2,220 Added 2.53%
89,948 $30.6 Million
Q1 2024

May 24, 2024

BUY
$293.94 - $358.71 $21.3 Million - $26 Million
72,549 Added 477.96%
87,728 $31.4 Million
Q1 2024

May 14, 2024

SELL
$293.94 - $358.71 $3.66 Million - $4.47 Million
-12,467 Reduced 45.1%
15,179 $5.43 Million
Q4 2023

Feb 13, 2024

SELL
$253.85 - $299.46 $580,554 - $684,865
-2,287 Reduced 7.64%
27,646 $8.28 Million
Q3 2023

Nov 14, 2023

BUY
$266.54 - $302.43 $477,639 - $541,954
1,792 Added 6.37%
29,933 $8.18 Million
Q2 2023

Aug 09, 2023

BUY
$271.49 - $305.09 $302,982 - $340,480
1,116 Added 4.13%
28,141 $8.59 Million
Q1 2023

May 15, 2023

SELL
$246.13 - $285.47 $141,032 - $163,574
-573 Reduced 2.08%
27,025 $7.71 Million
Q4 2022

Feb 14, 2023

BUY
$205.51 - $253.93 $1.29 Million - $1.59 Million
6,259 Added 29.33%
27,598 $6.75 Million
Q3 2022

Nov 10, 2022

SELL
$189.27 - $231.83 $243,211 - $297,901
-1,285 Reduced 5.68%
21,339 $4.32 Million
Q2 2022

Aug 11, 2022

BUY
$194.09 - $276.37 $50,269 - $71,579
259 Added 1.16%
22,624 $4.5 Million
Q1 2022

May 13, 2022

SELL
$245.33 - $277.77 $336,592 - $381,100
-1,372 Reduced 5.78%
22,365 $5.98 Million
Q4 2021

Feb 14, 2022

SELL
$236.63 - $276.44 $97,254 - $113,616
-411 Reduced 1.7%
23,737 $6.35 Million
Q3 2021

Nov 16, 2021

SELL
$248.9 - $280.09 $408,196 - $459,347
-1,640 Reduced 6.36%
24,148 $6.37 Million
Q2 2021

Aug 13, 2021

BUY
$242.95 - $267.0 $2.59 Million - $2.84 Million
10,649 Added 70.34%
25,788 $6.7 Million
Q1 2021

May 17, 2021

SELL
$221.01 - $248.82 $1.97 Million - $2.22 Million
-8,934 Reduced 37.11%
15,139 $3.69 Million
Q4 2020

Feb 17, 2021

BUY
$202.01 - $245.04 $3.66 Million - $4.44 Million
18,128 Added 304.93%
24,073 $5.9 Million
Q3 2020

Nov 13, 2020

SELL
$177.77 - $215.81 $4,088 - $4,963
-23 Reduced 0.39%
5,945 $1.24 Million
Q2 2020

Aug 13, 2020

SELL
$144.67 - $207.03 $73,058 - $104,550
-505 Reduced 7.8%
5,968 $1.08 Million
Q1 2020

May 08, 2020

SELL
$126.5 - $225.1 $87,411 - $155,544
-691 Reduced 9.65%
6,473 $1.08 Million
Q4 2019

Feb 10, 2020

BUY
$197.98 - $220.53 $319,341 - $355,714
1,613 Added 29.06%
7,164 $1.5 Million
Q3 2019

Nov 06, 2019

BUY
$205.4 - $221.82 $205 - $221
1 Added 0.02%
5,551 $1.2 Million
Q2 2019

Aug 12, 2019

BUY
$180.24 - $205.58 $31,181 - $35,565
173 Added 3.22%
5,550 $1.14 Million
Q1 2019

May 06, 2019

BUY
$152.46 - $198.0 $13,416 - $17,424
88 Added 1.66%
5,377 $1.07 Million
Q4 2018

Feb 15, 2019

SELL
$145.0 - $178.65 $5,800 - $7,146
-40 Reduced 0.75%
5,289 $829,000
Q3 2018

Nov 14, 2018

SELL
$163.25 - $177.68 $15,508 - $16,879
-95 Reduced 1.75%
5,329 $948,000
Q2 2018

Aug 14, 2018

BUY
$155.17 - $179.78 $39,258 - $45,484
253 Added 4.89%
5,424 $920,000
Q1 2018

May 09, 2018

SELL
$148.01 - $168.91 $4,292 - $4,898
-29 Reduced 0.56%
5,171 $830,000
Q4 2017

Feb 08, 2018

BUY
$143.51 - $159.74 $45,492 - $50,637
317 Added 6.49%
5,200 $804,000
Q3 2017

Nov 16, 2017

BUY
$138.36 - $147.87 $57,419 - $61,366
415 Added 9.29%
4,883 $689,000
Q2 2017

Aug 17, 2017

BUY
N/A
1,187 Added 36.18%
4,468 $617,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,281
3,281 $456,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.